Structures by: Moussaif A.
Total: 17
2-Methyl-4-(pyridin-2-yl)-3<i>H</i>-1,5-benzodiazepine
C15H13N3
IUCrData (2018) 3, 7 x180953
a=5.9642(6)Å b=17.7004(17)Å c=11.3963(11)Å
α=90° β=100.6950(10)° γ=90°
4-Phenyl-5a,6,7,8,9,9a-hexahydro-1<i>H</i>-1,5-benzodiazepin-2(5<i>H</i>)-one
C15H18N2O
IUCrData (2018) 3, 7 x181011
a=11.4283(18)Å b=9.2294(15)Å c=12.3632(19)Å
α=90° β=96.890(2)° γ=90°
Ethyl 5-(4-methylphenyl)-2,4,5,7-tetraazatricyclo[6.4.0.0^2,6^]dodeca-1(8),3,6,9,11-pentaene-3-carboxylate
C18H16N4O2
IUCrData (2018) 3, 6 x180892
a=9.2366(11)Å b=10.2045(12)Å c=16.1922(18)Å
α=90° β=92.144(2)° γ=90°
Ethyl 2-(5-methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-7-yl)pent-4-enoate
C13H16N4O2
IUCrData (2018) 3, 9 x181280
a=9.069(5)Å b=13.319(7)Å c=11.851(7)Å
α=90° β=112.161(7)° γ=90°
4-Phenyl-2,5,5a,6,7,8,9,9a-hexahydro-1<i>H</i>-1,5-benzodiazepine-2-thione ethanol monosolvate
C15H18N2S,C2H6O
IUCrData (2018) 3, 9 x181276
a=12.0255(2)Å b=8.9303(2)Å c=15.8822(3)Å
α=90° β=95.8130(10)° γ=90°
2,3-Dihydrobenz[4,5]imidazo[2,1-<i>b</i>]thiazole
C9H8N2S
IUCrData (2016) 1, 12 x161948
a=12.7440(8)Å b=11.4820(7)Å c=12.8707(8)Å
α=90° β=118.2340(10)° γ=90°
3-[2-(2-Amino-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)ethyl]-1,3-oxazolidin-2-one
C12H14N4O2
IUCrData (2016) 1, 12 x161895
a=9.0504(2)Å b=9.06120(10)Å c=14.3565(2)Å
α=90° β=90° γ=90°
3-[2-(5-Oxo-4,4-diphenyl-2-sulfanylideneimidazolidin-1-yl)ethyl]-1,3-oxazolidin-2-one
C20H19N3O3S
IUCrData (2017) 2, 7 x171041
a=9.1211(6)Å b=14.6521(9)Å c=14.2448(9)Å
α=90° β=104.0370(10)° γ=90°
1-(1,3-Benzothiazol-2-yl)-3-(2-hydroxyethyl)imidazolidin-2-one
C12H13N3O2S
Acta Crystallographica Section E (2020) 76, 3 370-376
a=7.2863(2)Å b=13.9178(5)Å c=11.6156(4)Å
α=90° β=98.8660(10)° γ=90°
(2<i>Z</i>)-2-(4-Fluorobenzylidene)-4-(prop-2-yn-1-yl)-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C18H12FNOS
Acta Crystallographica Section E (2019) 75, 3 372-377
a=4.0602(2)Å b=13.8983(5)Å c=14.2620(5)Å
α=117.809(2)° β=93.155(2)° γ=94.416(2)°
C11H12N2S
C11H12N2S
Acta Crystallographica Section E (2001) 57, 4 o364-o365
a=6.6159(7)Å b=8.5070(10)Å c=9.4680(10)Å
α=88.57(6)° β=72.53(9)° γ=80.89(4)°
1-Benzyl-2-[1-(5-methyl-1H-pyrazol-3-yl)-2-phenylethyl]benzimidazole
C26H24N4
Acta Crystallographica, Section E (2005) 61, 8 o2718-o22719
a=10.244(5)Å b=10.601(5)Å c=11.404(5)Å
α=64.499(5)° β=74.587(5)° γ=89.556(5)°
<i>N</i>'-(1-Allyl-2-oxoindolin-3-ylidene)benzohydrazide
C18H15N3O2
Acta Crystallographica Section E (2010) 66, 8 o1905
a=7.5921(2)Å b=15.1968(4)Å c=12.8716(3)Å
α=90.00° β=94.481(2)° γ=90.00°
1-Benzyl-3-methylquinoxalin-2(1<i>H</i>)-one
C16H14N2O
Acta Crystallographica Section E (2010) 66, 8 o1922
a=7.4433(2)Å b=17.5444(5)Å c=18.0598(7)Å
α=118.034(2)° β=100.217(2)° γ=92.7260(10)°
3-[2-(1<i>H</i>-Benzimidazol-2-ylsulfanyl)ethyl]-1,3-oxazolidin-2-one
C12H13N3O2S
Acta Crystallographica Section E (2010) 66, 12 o3137
a=8.2580(10)Å b=10.0740(10)Å c=29.201(3)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>'-(3-Methylquinoxalin-2-yl)-<i>N</i>'-phenylbenzohydrazide
C22H18N4O
Acta Crystallographica Section E (2011) 67, 6 o1374
a=18.6809(12)Å b=10.5840(8)Å c=9.5860(6)Å
α=90.00° β=100.108(3)° γ=90.00°
2-Phenylthieno[2,3-<i>b</i>]quinoxaline
C16H10N2S
Acta Crystallographica Section E (2012) 68, 2 o396
a=6.3875(3)Å b=16.2896(8)Å c=11.6054(6)Å
α=90.00° β=96.039(3)° γ=90.00°